FdaApplication

ANDA 208557

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTARO PHARMACEUTICAL INDUSTRIES LTD
application_typeANDA
approval_date2025-03-03

Products (4)

ProductActive ingredientStrengthDosage form
RIVAROXABANRIVAROXABAN20MGTABLET;ORAL
RIVAROXABANRIVAROXABAN10MGTABLET;ORAL
RIVAROXABANRIVAROXABAN2.5MGTABLET;ORAL
RIVAROXABANRIVAROXABAN15MGTABLET;ORAL

4 products